| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
| mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
| mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.05 |
| mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.05 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
| mRNA |
BI-2536 |
FIMM |
pan-cancer |
AAC |
-0.27 |
0.05 |
| mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.05 |
| mRNA |
SGC0946 |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.05 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.05 |